BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 16872506)

  • 21. Immunohistochemical distinction of follicular thyroid adenomas and follicular carcinomas.
    Bryson PC; Shores CG; Hart C; Thorne L; Patel MR; Richey L; Farag A; Zanation AM
    Arch Otolaryngol Head Neck Surg; 2008 Jun; 134(6):581-6. PubMed ID: 18559722
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ECM1 expression in thyroid tumors--a comparison of real-time RT-PCR and IHC.
    Lal G; Padmanabha L; Nicholson R; Smith BJ; Zhang L; Howe JR; Robinson RA; O'Dorisio MS
    J Surg Res; 2008 Sep; 149(1):62-8. PubMed ID: 18374945
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bayesian neural networks for bivariate binary data: an application to prostate cancer study.
    Chakraborty S; Ghosh M; Maiti T; Tewari A
    Stat Med; 2005 Dec; 24(23):3645-62. PubMed ID: 16138362
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Challenges in projecting clustering results across gene expression-profiling datasets.
    Lusa L; McShane LM; Reid JF; De Cecco L; Ambrogi F; Biganzoli E; Gariboldi M; Pierotti MA
    J Natl Cancer Inst; 2007 Nov; 99(22):1715-23. PubMed ID: 18000217
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gene expression-based molecular diagnostic system for malignant gliomas is superior to histological diagnosis.
    Shirahata M; Iwao-Koizumi K; Saito S; Ueno N; Oda M; Hashimoto N; Takahashi JA; Kato K
    Clin Cancer Res; 2007 Dec; 13(24):7341-56. PubMed ID: 18094416
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Improving gene expression cancer molecular pattern discovery using nonnegative principal component analysis.
    Han X
    Genome Inform; 2008; 21():200-11. PubMed ID: 19425159
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An application of methods for the probabilistic three-class classification of pregnancies of unknown location.
    Van Calster B; Condous G; Kirk E; Bourne T; Timmerman D; Van Huffel S
    Artif Intell Med; 2009 Jun; 46(2):139-54. PubMed ID: 19157812
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of immunohistochemical biomarkers for papillary thyroid carcinoma using gene expression profiling.
    Murphy KM; Chen F; Clark DP
    Hum Pathol; 2008 Mar; 39(3):420-6. PubMed ID: 18261626
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An expression-based site of origin diagnostic method designed for clinical application to cancer of unknown origin.
    Tothill RW; Kowalczyk A; Rischin D; Bousioutas A; Haviv I; van Laar RK; Waring PM; Zalcberg J; Ward R; Biankin AV; Sutherland RL; Henshall SM; Fong K; Pollack JR; Bowtell DD; Holloway AJ
    Cancer Res; 2005 May; 65(10):4031-40. PubMed ID: 15899792
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnosis and genetic subtypes of leukemia combining gene expression and flow cytometry.
    Basso G; Case C; Dell'Orto MC
    Blood Cells Mol Dis; 2007; 39(2):164-8. PubMed ID: 17588788
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gene selection based on multi-class support vector machines and genetic algorithms.
    Souza BF; Carvalho AP
    Genet Mol Res; 2005 Sep; 4(3):599-607. PubMed ID: 16342045
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Differential gene expression signatures in well differentiated thyroid carcinomas].
    Heitz PU; Zhao J; Leonard-Meier Ch; Gemsenjäger E; Odermatt B; Brunner E
    Verh Dtsch Ges Pathol; 2003; 87():185-7. PubMed ID: 16888911
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Optimal aggregation of binary classifiers for multiclass cancer diagnosis using gene expression profiles.
    Yukinawa N; Oba S; Kato K; Ishii S
    IEEE/ACM Trans Comput Biol Bioinform; 2009; 6(2):333-43. PubMed ID: 19407356
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Down-regulation of transcription elogation factor A (SII) like 4 (TCEAL4) in anaplastic thyroid cancer.
    Akaishi J; Onda M; Okamoto J; Miyamoto S; Nagahama M; Ito K; Yoshida A; Shimizu K
    BMC Cancer; 2006 Nov; 6():260. PubMed ID: 17076909
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Meta-analysis and meta-review of thyroid cancer gene expression profiling studies identifies important diagnostic biomarkers.
    Griffith OL; Melck A; Jones SJ; Wiseman SM
    J Clin Oncol; 2006 Nov; 24(31):5043-51. PubMed ID: 17075124
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Consensus analysis of multiple classifiers using non-repetitive variables: diagnostic application to microarray gene expression data.
    Su Z; Hong H; Perkins R; Shao X; Cai W; Tong W
    Comput Biol Chem; 2007 Feb; 31(1):48-56. PubMed ID: 17303535
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ensemble methods for classification of patients for personalized medicine with high-dimensional data.
    Moon H; Ahn H; Kodell RL; Baek S; Lin CJ; Chen JJ
    Artif Intell Med; 2007 Nov; 41(3):197-207. PubMed ID: 17719213
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Does the 3-gene diagnostic assay accurately distinguish benign from malignant thyroid neoplasms?
    Shibru D; Hwang J; Khanafshar E; Duh QY; Clark OH; Kebebew E
    Cancer; 2008 Sep; 113(5):930-5. PubMed ID: 18661512
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predicting features of breast cancer with gene expression patterns.
    Lu X; Lu X; Wang ZC; Iglehart JD; Zhang X; Richardson AL
    Breast Cancer Res Treat; 2008 Mar; 108(2):191-201. PubMed ID: 18297396
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multi-class cancer classification through gene expression profiles: microRNA versus mRNA.
    Peng S; Zeng X; Li X; Peng X; Chen L
    J Genet Genomics; 2009 Jul; 36(7):409-16. PubMed ID: 19631915
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.